期刊文献+

透明质酸注射矫正泪槽畸形 被引量:6

Clinical application of hyaluronic acid on the treatment of tear through deformity
原文传递
导出
摘要 目的评价应用透明质酸(HA)注射矫正泪槽畸形的临床效果。方法自2010年6月至2012年6月,对35例矫正泪槽沟畸形患者进行HA注射治疗,注射剂量为0.5~1.5ml。观察注射后的临床效果、疗效时间、不良反应等。结果所有的注射部位均于注射后即刻得到改善。注射后随访患者,1、3、6个月分别有95.5%、84.7%、52.3%的注射部位维持了改善的效果;6~12个月有43.7%的注射部位维持了改善的效果;12-18个月有15.8%的注射部位维持了改善的效果。注射治疗中,未出现急慢性过敏反应及感染、肉芽肿、血管栓塞等并发症。结论HA作为暂时性填充剂,治疗泪槽沟畸形安全、可靠。 Objective To evaluate the clinical effects of hyaluronic acid (HA) on the treatment of tear trough deformity. Methods From June 2010 to June 2012, totally 35 patients with tear trough deformity re- ceived HA injection with a volume of 0.5-1.5 ml at various layers of soft tissues in the site of trough. The clini- cal effects, lasting time and side effects were observed. Results The tear trough deformities in all cases were improved immediately. The improvement percentages were 95.5% , 84.7% and 52.3% at 1,3 and 6 months, respectively. After follow-up, the effect of the improvement were 43.7% during 6-12 months and 15.8% dur- ing 12-18 months. Non severe complications such as allergic reaction, infection, granulomas and embolism were found after injection. Conclusion HA is a safe and effective dermal filler for the treatment of tear trough deformity.
出处 《中国美容整形外科杂志》 CAS 2012年第10期580-583,共4页 Chinese Journal of Aesthetic and Plastic Surgery
关键词 透明质酸 泪槽沟畸形 皮肤填充剂 Hyaluronic acid Tear trough deformity Dermal filler
  • 相关文献

参考文献17

  • 1American Society of Plastic Surgeons. National Plastic Surgery [EB/OL]. [ 2012-06-20]. http://~vww, plasticsurgery, org/ News-and-Resources/2011-Statistics-. html.
  • 2Viana GA, Osaki MH, Cariello A J, et al. Treatment of the tear trough deformity with hyaluronic acid [ J ]. Aesthet Surg J, 2011,31 (2) :225-231.
  • 3Dayan SH, Arkins JP, Somenek M. Restylane persisting in lower eyelids for 5 years [ J ]. J Cosmet Demmtol, 2012,11 (3) : 237- 238.
  • 4Matarasso SL, Carruthers JD, JeweU ML; Restylane Consensus Group. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane) [ J ]. Plast Reconstr Surg, 2006,117(3 Suppl):3S-43S.
  • 5Rebecca T, Arlene MR, Kelly P, et al. Brighter eyes: combined upper cheek and tear trough augmentation: a systematic approach utilizing two complementary hyaluronic acid riflers [ J ]. J Drugs Dermatol, 2012,11 (9) :1094-1097.
  • 6Lowe N J, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review[ J]. Dermatol Sttrg, 2005,31 ( 11 Pt 2 ) : 1616- 1625.
  • 7吴溯帆,石杭燕,严晟,陈达,郭金才,陈永.透明质酸在面部美容中的应用[J].中国美容整形外科杂志,2007,18(5):324-328. 被引量:32
  • 8Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation[J]. Dermatol Surg, 2002,28(6) :491-494.
  • 9Coleman SR; Plastic Surgery Educational Foundation DATA Committee. Cross-linked hyaluronic acid fillers [ J ]. Plast Reconstr Surg, 2006 ,117(2) :661-665.
  • 10Park SW, Woo SJ, Park KH, et al. Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections[ J]. Am J Ophthalmol, 2012,154(4) :653-662. el.

二级参考文献38

  • 1吴海山,钱齐荣,顾其胜.关节内注射透明质酸钠预防兔骨关节炎的实验研究[J].中华骨科杂志,1996,16(1):37-39. 被引量:93
  • 2马晓泉,纪斌平,于红伟.透明质酸治疗膝骨关节炎临床效果观察[J].实用骨科杂志,2007,13(1):47-49. 被引量:9
  • 3[1]AMERICAN SOCIETY of PLASTIC SURGEONS (ASPS).National Plastic Surgery[EB/OL].[ 2007-06-20 ].http://www.plasticsurgery.org/media/statistics/index.cfm.
  • 4[2]MATARASSO S L,CARRUTHERS J D,JEWELL M L,et al.Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane)[J].Plast Reconstr Surg,2006,117(3suppl):3S-34S.
  • 5[3]HASCALL V C,LAURENT T C.Hyaluronan:structure and function[EB/OL].[ 2007-06-20 ].http://www.glycoforum.gr.jp/science/hyaluronan/HA01/HA01E.html#I.
  • 6[4]MEYER K,PALMER J W.The polysaccharide of the vitreous humor[J].Biol Chem,1934,107:629-634.
  • 7[5]ALBERTS B,JOHNSON A,LEWIS J,et al.The extracellular matrix of animals[M].The Molecular Biology of the Cell.4th Ed.New York:Garland Science,2002:1090-1093.
  • 8[6]GOA K L,BENFIELD P.Hyaluronic acid.A review of its pharmacology and use as a surgical aid in ophthalmology,and its therapeutic potential in joint disease and wound healing[J].Drugs,1994,47(3):536-536.
  • 9[7]NARINS R S,BOWMAN P H.Injectable skin fillers[J].Clin Plast Surg,2005,32(2):151-162.
  • 10[8]BIESMAN B.Soft tissue augmentation using Restylane[J].Facial Plast Surg,2004,20(2):171-177.

共引文献31

同被引文献67

  • 1漆光平,杜亚政,潘爱华,杨科球.乳胶血管灌注的技术探讨[J].湖南医科大学学报,2000,5(4):411-412. 被引量:14
  • 2吴溯帆,石杭燕,严晟,陈达,郭金才,陈永.透明质酸在面部美容中的应用[J].中国美容整形外科杂志,2007,18(5):324-328. 被引量:32
  • 3Beasley KL, Weiss MA, Weiss RA. Hyaluronic acid fillers: a comprehensive review [ J ]. Facial Plast Surg, 2009,25 (2) :86-94.
  • 4Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications[ Jl. Dermatol Surg, 2009,35 Suppl 2:1672-1680.
  • 5Richard N, Shermann RN. Avoiding dermal filler complications[ J]. Clin Dermatol, 2009,27 : $23-$32.
  • 6Peter S, Mennel S. Retinal branch artery occlusion following injection of hyaluronic acid (Restylane) [J]. Clin Experiment Ophthalmol, 2006,34(4) :363- 364.
  • 7Hwang YH, Hwang JH, Kim JS, et al. Branch retinal artery occlusion after periocular dermal filler injection [ Jl. Retin Cases Brief Rep, 2008, 2:338-341.
  • 8Sung MS, Kim HG, Woo KI, et al. Ocular isehemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxy- lapatite filler[J]. Ophthal Plast Reconstr Surg, 2010,26(4) :289-291.
  • 9Kwon DY, Park MH, Koh SB, et al. Multiple arterial embolism after illicit intranasal injection of collagenous material[ J]. Dermatol Surg, 2010, 36(7) :1196-1199.
  • 10Park SW, Woo SJ, Park KH, et al. Iatmgenic retinal artery occlusion caused by cosmetic facial filler injections[J]. Am J Ophthalmol, 2012,154(4) :653- 662.

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部